ATE419844T1 - Verwendung von sesquiterpenalkohol zur regulierung des autonomen nervensystems - Google Patents

Verwendung von sesquiterpenalkohol zur regulierung des autonomen nervensystems

Info

Publication number
ATE419844T1
ATE419844T1 AT01902822T AT01902822T ATE419844T1 AT E419844 T1 ATE419844 T1 AT E419844T1 AT 01902822 T AT01902822 T AT 01902822T AT 01902822 T AT01902822 T AT 01902822T AT E419844 T1 ATE419844 T1 AT E419844T1
Authority
AT
Austria
Prior art keywords
alcohol
sesquiterpen
regulate
nervous system
autonomous nervous
Prior art date
Application number
AT01902822T
Other languages
English (en)
Inventor
Yoshinao Nagashima
Keiichi Sugata
Yukihiro Yada
Kazuyuki Fukuda
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Application granted granted Critical
Publication of ATE419844T1 publication Critical patent/ATE419844T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Confectionery (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Air Conditioning Control Device (AREA)
  • Fats And Perfumes (AREA)
AT01902822T 2000-02-10 2001-02-09 Verwendung von sesquiterpenalkohol zur regulierung des autonomen nervensystems ATE419844T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000038260 2000-02-10

Publications (1)

Publication Number Publication Date
ATE419844T1 true ATE419844T1 (de) 2009-01-15

Family

ID=18562022

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01902822T ATE419844T1 (de) 2000-02-10 2001-02-09 Verwendung von sesquiterpenalkohol zur regulierung des autonomen nervensystems

Country Status (6)

Country Link
US (3) US7125911B2 (de)
EP (1) EP1170005B1 (de)
JP (2) JP4288883B2 (de)
AT (1) ATE419844T1 (de)
DE (1) DE60137285D1 (de)
WO (1) WO2001058435A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE419844T1 (de) 2000-02-10 2009-01-15 Kao Corp Verwendung von sesquiterpenalkohol zur regulierung des autonomen nervensystems
JP4721451B2 (ja) * 2003-02-28 2011-07-13 コンソリデーティッド リサーチ オブ リッチモンド，インコーポレイテッド 被験者の覚醒／睡眠状態を示す情報を使用する行動療法の実施を容易にするための自動化システムおよび装置
JP4515063B2 (ja) * 2003-09-11 2010-07-28 花王株式会社 高揮散性複合粒子
JP4236563B2 (ja) * 2003-11-13 2009-03-11 花王株式会社 寝具用シート
EP1743633B1 (de) * 2004-04-06 2010-08-18 Taiyokagaku Co., Ltd. Verwendung einer kombination von theanin und serotonin gegen schlafstörung
EP1806133A1 (de) * 2004-10-14 2007-07-11 Daikin Industries, Ltd. Verfahren zur veränderung der umgebung und bei dem verfahren verwendete sprühflüssigkeit und sprühgerät
JP4886202B2 (ja) * 2005-03-16 2012-02-29 花王株式会社 月経前及び／又は月経中の身体的及び／又は精神的不快の緩和剤
GB0620279D0 (en) * 2006-10-13 2006-11-22 Reckitt Benckiser Uk Ltd Compositions
US7707655B2 (en) * 2006-12-15 2010-05-04 Kimberly-Clark Worldwide, Inc. Self warming mask
US8275635B2 (en) * 2007-02-16 2012-09-25 Bodymedia, Inc. Integration of lifeotypes with devices and systems
CN103284991B (zh) * 2007-05-29 2015-09-09 财团法人大阪生物科学研究所 食品组合物
DE102010036179A1 (de) 2010-09-02 2012-03-08 Beiersdorf Ag Kosmetische Zubereitungen mit beruhigender Wirkung
ITBO20110100A1 (it) * 2011-03-02 2012-09-03 Big Rock Technologies Ltd Metodo e dispositivo di regolazione per regolare l'umore di almeno un individuo
JP2012031199A (ja) * 2011-10-31 2012-02-16 Kao Corp 月経前及び／又は月経中の身体的及び／又は精神的不快の緩和剤
JP5349564B2 (ja) * 2011-10-31 2013-11-20 花王株式会社 月経前及び／又は月経中の身体的及び／又は精神的不快の緩和剤
JP2017025029A (ja) * 2015-07-23 2017-02-02 株式会社デンソー 混合溶剤、および混合溶剤放出装置
JP6839610B2 (ja) * 2017-05-31 2021-03-10 株式会社ファンケル マッサージ用化粧料
WO2020004182A1 (ja) * 2018-06-25 2020-01-02 高砂香料工業株式会社 睡眠改善剤
US20220257176A1 (en) * 2019-07-10 2022-08-18 Panasonic Intellectual Property Management Co., Ltd. Nap evaluation device, nap evaluation system, nap evaluation method, and program
AU2020317501B2 (en) * 2019-07-24 2024-11-14 Asahi Group Holdings, Ltd. Agent for regulating female hormone secretion and agent for alleviating unpleasant symptoms
JP2021104190A (ja) * 2019-12-26 2021-07-26 株式会社豊田中央研究所 空間調節装置および空間調節方法
EP4159069A4 (de) * 2020-06-01 2025-07-30 Venex Co Ltd Verfahren zur verbesserung des parasympathischen nervensystems, schlafqualitäts- und ermüdungsfestigkeit
US12409202B2 (en) 2021-07-30 2025-09-09 Fujicco Co., Ltd. Autonomic nerve regulator and cognitive function improver

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB294587A (en) * 1927-01-27 1928-07-27 Wilfrid Stanley Leech Improvements in or relating to ventilating and disinfecting apparatus
FR4055M (de) * 1964-01-20 1966-04-04
US3632782A (en) * 1967-01-13 1972-01-04 American Home Prod Thymol as an anti-influenza agent
DE2317583C3 (de) * 1973-04-07 1978-07-13 Deutsche Gold- Und Silber-Scheideanstalt Vormals Roessler, 6000 Frankfurt Verfahren zur Reinigung von a- Bisabolol
US4254145A (en) * 1978-08-16 1981-03-03 American Cyanamid Company Topical application of prostaglandin hypotensive agents
EP0143248B1 (de) * 1983-10-03 1986-09-03 Kali-Chemie Aktiengesellschaft Verfahren zur Umsetzung von Fluorwasserstoff mit Fettsäureestern
JPS6133129A (ja) 1984-07-25 1986-02-17 Nitto Electric Ind Co Ltd 基剤組成物および外用医薬組成物
KR920005729B1 (ko) * 1984-09-06 1992-07-16 미쓰비시 레이온 캄파니 리미티드 방향성 섬유
JPS61267526A (ja) 1984-11-14 1986-11-27 インタ−ナシヨナル　フレイバ−ス　アンド　フレグランシス　インコ−ポレイテツド 人間のストレスに対する生理的及び、又は主観的反応性を減少させる医薬
EP0183436B1 (de) * 1984-11-14 1991-07-03 INTERNATIONAL FLAVORS & FRAGRANCES INC. Verfahren, Zusammensetzungen und ihre Anwendungen gegen Stress
JPH0370501A (ja) * 1989-08-09 1991-03-26 Toray Ind Inc スリッパ底敷用シート状物
US5095015A (en) * 1990-07-24 1992-03-10 Neurogen Corporation Certain azacycloalkyl imidazopyrimidines; a new class of gaba brain receptor ligands
JPH04128234A (ja) 1990-09-19 1992-04-28 Suntory Ltd 入眠促進剤
JP3044480B2 (ja) 1990-11-30 2000-05-22 イカリ薬品株式会社 昇華性防虫剤
US5316939A (en) * 1991-04-02 1994-05-31 Kao Corporation Microorganism belonging to the genus Rhodococcus, and process for producing sec-cedrenol and cedrenone
JPH05255688A (ja) 1992-03-13 1993-10-05 Kanebo Ltd 鎮静用精油を含む香粧品
US5195514A (en) * 1992-04-21 1993-03-23 Dongfeng Liu Portable hand-held medicinal vaporizer
JPH0640911A (ja) 1992-07-22 1994-02-15 Suntory Ltd 入眠促進剤
JP3519747B2 (ja) * 1992-09-25 2004-04-19 高砂香料工業株式会社 鎮静効果を与える香料改質剤
FR2697133B1 (fr) * 1992-10-28 1995-01-13 Transbiotech Composition biocide et/ou biostatique et ses applications.
JPH07148280A (ja) * 1993-10-04 1995-06-13 Koki Bussan Kk マスク
JPH08225437A (ja) 1995-02-22 1996-09-03 T Hasegawa Co Ltd 芳香性線香
JPH0920646A (ja) 1995-07-06 1997-01-21 Kobayashi Pharmaceut Co Ltd 浴用芳香剤組成物
GB9604942D0 (en) * 1996-03-08 1996-05-08 Jones Gareth Device for vaporising essential oils
JP3240345B2 (ja) * 1996-07-11 2001-12-17 小林製薬株式会社 経口催眠剤、催眠性飲食物及び催眠性餌料
JPH1036246A (ja) 1996-07-24 1998-02-10 Pola Chem Ind Inc メラニン産生抑制剤及び皮膚外用剤
JPH10113369A (ja) 1996-08-21 1998-05-06 Kao Corp 美容方法
US5955034A (en) * 1997-08-20 1999-09-21 S. C. Johnson & Son, Inc. Air freshener taper candle product
JP2000042125A (ja) 1998-05-22 2000-02-15 Kao Corp マスク
JPH11343497A (ja) * 1998-05-29 1999-12-14 Naris Cosmetics Co Ltd 化粧料
JP4194196B2 (ja) * 1999-02-22 2008-12-10 花王株式会社 浴用剤組成物
DE19931709A1 (de) * 1999-07-08 2001-01-11 Haarmann & Reimer Gmbh Neue tetracyclische Acetale
JP2001049286A (ja) 1999-08-05 2001-02-20 Pola Chem Ind Inc ストレス緩和用の香料組成物及びそれを含有する組成物
ATE419844T1 (de) 2000-02-10 2009-01-15 Kao Corp Verwendung von sesquiterpenalkohol zur regulierung des autonomen nervensystems

Also Published As

Publication number Publication date
EP1170005A4 (de) 2004-10-20
DE60137285D1 (de) 2009-02-26
JP2009051835A (ja) 2009-03-12
JP4288883B2 (ja) 2009-07-01
EP1170005A1 (de) 2002-01-09
US7125911B2 (en) 2006-10-24
WO2001058435A1 (en) 2001-08-16
US20040048933A1 (en) 2004-03-11
JP5007833B2 (ja) 2012-08-22
EP1170005B1 (de) 2009-01-07
US20020151600A1 (en) 2002-10-17
US20040039065A1 (en) 2004-02-26

Similar Documents

Publication Publication Date Title
ATE419844T1 (de) Verwendung von sesquiterpenalkohol zur regulierung des autonomen nervensystems
DE602005023003D1 (de) Verwendung einer kombination von theanin und serotonin gegen schlafstörung
NO996133L (no) Olje-i-vann-vaksinesammensetninger
AR043188A1 (es) Metodos y composiciones para el tratamiento de enfermedades y trastornos asociados con niveles elevados de citoquinas proinflamatorias
ATE259230T1 (de) Verwendung von vasopressin-antagonisten zur behandlung von störungen oder erkrankungen des innenohres
HUP0104258A2 (hu) HMG-CoA reduktáz inhibítort tartalmazó stabil gyógyszerkészítmények
EP2353577A3 (de) W/O Emulsion enthaltend einen elastomerische Silikonemulgator und ein flüchtiges lineares Alkan
ATE535239T1 (de) Formulierungen enthaltend amiodaron und sulfoalkylethercyclodextrin
AR003496A1 (es) Procedimiento de tratamiento cosmetico no terapeutico de desordenes asociados con un exceso de sintesis y/o liberacion del cgrp y/o de sustancia p utilizacion de al menos un extracto de celulas de la menos un vegetal de la familia de las iridaceas y composicion cosmetica o farmaceutica que comprende dicho extracto
ATE265236T1 (de) Vorrichtung zur abgabe von duftstoffen
DE60037578D1 (de) Verwendung von triacetyluridin zur behandlung von mitochondrialen erkrankungen
BG105112A (bg) Средство с антидепресивно действие
BRPI0414858A (pt) métodos para preparação de corpos de óleo compreendendo ingredientes ativos
DK1397681T3 (da) Fremgangsmåde til identificering af midler til behandling af diabetes
DE60108976D1 (de) Vorrichtung zur unterstützung von aktivitäten
SG165326A1 (en) Compositions and methods to counteract oral malodour
ATE322906T1 (de) Verwendung von langem pentraxin ptx3 zur behanlung von durch geänderte aktivität des fgf-2 wachstumsfaktors hervorgerufene krankheiten
DE60229240D1 (de) Verwendung eines analoges des vitamins d3 zur behandlung des autoimmunen diabetes
DE60117122D1 (de) Verwendung von mirtazapin zur behandlung von schlafstörungen
MXPA04010816A (es) Acidos aminoalcanfosfonicos sustituidos para el tratamiento de dolor neuropatico, trastornos afectivos y de la atencion, esquizofrenia, tinitus, miopia y otros trastornos oculares.
DE60228988D1 (de) Monohyroxycarbamezepin zur verwendung bei der herstellung eines medikaments zur behandlung von affektiver psychose, aufmerksamkeits störungen und neuropathischen schmerzen
ATE277060T1 (de) 1,5-anhydro-d-fruktose substituiert mit einer hydrophoben gruppe zur verwendung als antioxidant und/oder emulgator
ATE239458T1 (de) Verwendung von selegilin zur behandlung von epileptischen erkrankungen
ATE398134T1 (de) Neue analoga von nitrobenzylthioinosin
WO2002070069A3 (fr) Utilisation d'un ou plusieurs shogaol(s) en tant qu'aphrodisiaque

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties